Stay updated on Nintedanib for Progressive Fibrosing ILD Clinical Trial
Sign up to get notified when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.

Latest updates to the Nintedanib for Progressive Fibrosing ILD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 from the page’s revision history.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check45 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check74 days agoChange DetectedRevision: v3.4.2 was added. The prior government funding lapse notice and Revision: v3.4.1 were removed.SummaryDifference0.2%

- Check81 days agoChange DetectedAdded a site-wide government funding notice and updated the revision tag to v3.4.1, replacing the previous v3.4.0 revision.SummaryDifference0.2%

- Check88 days agoChange DetectedShow glossary added; metadata updates include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0, while the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nintedanib for Progressive Fibrosing ILD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nintedanib for Progressive Fibrosing ILD Clinical Trial page.